Publication | Closed Access

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial

VaccinationVaccine SafetyViral HepatitisMedicineImmunologyHepatitis BHepatitisVaccine EfficacyTri-antigenic VersusVaccine HesitancyPrecision Vaccinology